Sources | Names Used |
---|---|
CTRPv2 | navitoclax:sorafenib (1:1 mol/mol) |
PharmacoGx | navitoclax:sorafenib (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | S100A11 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-06 |
mRNA | CIB1 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
mRNA | NBPF15 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
mRNA | RAB13 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
mRNA | S100A6 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
mRNA | SP100 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-07 |
mRNA | XXbac-BPG246D15.9 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
mRNA | PXN | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
mRNA | C2orf47 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | MST1R | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-05 |